Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma
Chen, X., Habib, S., Alexandru, M., Chauhan, J., Evan, T., Troka, J. M., Rahimi, A., Esapa, B., Tull, T. J., Ng, W. Z., Fitzpatrick, A., Wu, Y., Geh, J. L. C., Lloyd-Hughes, H., Palhares, L. C. G. F., Adams, R., Bax, H. J., Whittaker, S., Jacków-Malinowska, J. & Karagiannis, S. N., 25 Sept 2024, In: Cancers. 16, 19, 3260.
Research output: Contribution to journal › Review article › peer-review